1-103619578-C-A
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 1 ACMG points: 1P and 0B. PP3
The NM_000699.4(AMY2A):c.538C>A(p.Leu180Ile) variant causes a missense change. The variant allele was found at a frequency of 0.000205 in 151,190 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: 𝑓 0.00021 ( 0 hom., cov: 28)
Exomes 𝑓: 0.000024 ( 0 hom. )
Failed GnomAD Quality Control
Consequence
AMY2A
NM_000699.4 missense
NM_000699.4 missense
Scores
7
9
3
Clinical Significance
Conservation
PhyloP100: 5.79
Genes affected
AMY2A (HGNC:477): (amylase alpha 2A) This gene encodes a member of the alpha-amylase family of proteins. Amylases are secreted proteins that hydrolyze 1,4-alpha-glucoside bonds in oligosaccharides and polysaccharides, catalyzing the first step in digestion of dietary starch and glycogen. This gene and several family members are present in a gene cluster on chromosome 1. This gene encodes an amylase isoenzyme produced by the pancreas. [provided by RefSeq, Jan 2015]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 1 ACMG points.
PP3
MetaRNN computational evidence supports a deleterious effect, 0.753
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
AMY2A | NM_000699.4 | c.538C>A | p.Leu180Ile | missense_variant | 4/10 | ENST00000414303.7 | NP_000690.1 | |
AMY2A | XM_047418085.1 | c.538C>A | p.Leu180Ile | missense_variant | 5/11 | XP_047274041.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
AMY2A | ENST00000414303.7 | c.538C>A | p.Leu180Ile | missense_variant | 4/10 | 1 | NM_000699.4 | ENSP00000397582 | P1 | |
AMY2A | ENST00000423678.2 | c.513+470C>A | intron_variant | 3 | ENSP00000390832 |
Frequencies
GnomAD3 genomes AF: 0.000205 AC: 31AN: 151074Hom.: 0 Cov.: 28
GnomAD3 genomes
AF:
AC:
31
AN:
151074
Hom.:
Cov.:
28
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000494 AC: 4AN: 80956Hom.: 0 AF XY: 0.0000503 AC XY: 2AN XY: 39772
GnomAD3 exomes
AF:
AC:
4
AN:
80956
Hom.:
AF XY:
AC XY:
2
AN XY:
39772
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome Data not reliable, filtered out with message: AS_VQSR AF: 0.0000240 AC: 35AN: 1460790Hom.: 0 Cov.: 32 AF XY: 0.0000234 AC XY: 17AN XY: 726712
GnomAD4 exome
Data not reliable, filtered out with message: AS_VQSR
AF:
AC:
35
AN:
1460790
Hom.:
Cov.:
32
AF XY:
AC XY:
17
AN XY:
726712
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000205 AC: 31AN: 151190Hom.: 0 Cov.: 28 AF XY: 0.000257 AC XY: 19AN XY: 73832
GnomAD4 genome
AF:
AC:
31
AN:
151190
Hom.:
Cov.:
28
AF XY:
AC XY:
19
AN XY:
73832
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
ESP6500AA
AF:
AC:
1
ESP6500EA
AF:
AC:
0
ExAC
AF:
AC:
4
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Mar 24, 2023 | The c.538C>A (p.L180I) alteration is located in exon 4 (coding exon 4) of the AMY2A gene. This alteration results from a C to A substitution at nucleotide position 538, causing the leucine (L) at amino acid position 180 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
BayesDel_addAF
Benign
T
BayesDel_noAF
Uncertain
CADD
Pathogenic
DANN
Uncertain
DEOGEN2
Uncertain
D;D
Eigen
Uncertain
Eigen_PC
Uncertain
FATHMM_MKL
Uncertain
D
LIST_S2
Pathogenic
D;.
M_CAP
Pathogenic
D
MetaRNN
Pathogenic
D;D
MetaSVM
Pathogenic
D
MutationAssessor
Pathogenic
H;H
MutationTaster
Benign
D
PrimateAI
Uncertain
T
PROVEAN
Benign
.;N
REVEL
Pathogenic
Sift
Uncertain
.;D
Sift4G
Uncertain
D;D
Polyphen
P;P
Vest4
MVP
MPC
3.3
ClinPred
D
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at